Fw: Health News: [Sprycel]

[Guest guest]

I found this article very instructive regarding the " business " of leukemia. We

are all participants in the for profit leukemia " market. " The extremely

overpriced leukemia drugs that we are forced to take in order to stay alive are

profit centers for large corporations. We are profit centers assuming we in the

U.S. are lucky enough to have access to Gleevec, Spryce, Tasigna, etc.

Has anyone given serious thought to our system that allows corporations to

profit from our misery???

Health News Alert

Alerts Health - My Alerts - Edit Alert

Friday, September 24, 2010 5:12 PM PDT

Sponsored Link

Special Offer - Free Trial of Blockbuster.com

Rent Movies from Blockbuster.com. Delivered Direct To Your Mailbox.

Click here to start today.

www.Blockbuster.com

Drug Sales In The Leukemia Market Will Be Driven By Therapies From Novartis,

Bristol-Myers Squibb, Biogen Idec, Roche ...

Medical News Today Fri, 24 Sep 2010 09:18 AM PDT

Decision Resources, one of the world's leading research and advisory firms for

pharmaceutical and healthcare issues, finds that growth in the leukemia market

will be driven mostly by chronic myelogenous leukemia (CML) therapies

(Novartis's Gleevec and Tasigna and Bristol-Myers Squibb's Sprycel) and chronic

lymphocytic leukemia (CLL) therapies (Biogen Idec/Roche's Rituxan and Cephalon's

Treanda ...

See more health stories that match my keyword

Visit Health

________________________________

You received this email because you subscribed to Alerts. Use this link

to unsubscribe from this alert. To change your communications preferences for

other business lines, please visit your Marketing Preferences. To learn

more about 's use of personal information, including the use of web

beacons in HTML-based email, please read our Privacy Policy. is located

at 701 First Avenue, Sunnyvale, CA 94089.